These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 29226855)
1. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer. Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855 [TBL] [Abstract][Full Text] [Related]
2. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Han Y; Liu Y; Nie L; Gui Y; Cai Z Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3. Sun J; Wang X; Fu C; Wang X; Zou J; Hua H; Bi Z Mol Biol Rep; 2016 May; 43(5):427-36. PubMed ID: 27022737 [TBL] [Abstract][Full Text] [Related]
4. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. Chen M; Li J; Zhuang C; Cai Z Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway. Zhuang J; He S; Wang G; Wang G; Ni J; Zhang S; Ye Y; Xia W Oncol Res; 2018 Sep; 26(8):1257-1265. PubMed ID: 29463348 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1. Zhang J; Shi Z; Nan Y; Li M Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504. Chen Q; Fu L PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567 [TBL] [Abstract][Full Text] [Related]
8. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b. Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C Biomed Pharmacother; 2017 Dec; 96():299-304. PubMed ID: 28992472 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936 [TBL] [Abstract][Full Text] [Related]
10. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Tuo Z; Zhang J; Xue W Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110 [TBL] [Abstract][Full Text] [Related]
11. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer. Lv Y; Li H; Li F; Liu P; Zhao X Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551 [TBL] [Abstract][Full Text] [Related]
13. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer. He YC; Bi YG; Jiang L Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962 [TBL] [Abstract][Full Text] [Related]
14. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion. Zhang C; Wang W; Lin J; Xiao J; Tian Y Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865 [TBL] [Abstract][Full Text] [Related]
15. Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer. Hu X; Feng H; Huang H; Gu W; Fang Q; Xie Y; Qin C; Hu X Technol Cancer Res Treat; 2019 Jan; 18():1533033819846638. PubMed ID: 31311442 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis. Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer. Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229 [TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Guo JQ; Li SJ; Guo GX Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway. Zheng L; Chen J; Zhou Z; He Z Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004 [TBL] [Abstract][Full Text] [Related]
20. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]